[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100627515":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":11,"locations":17,"responsibleParty":31,"collaborators":35,"id":38,"slug":10,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":42,"acronym":10,"eligibilityCriteria":43,"healthyVolunteers":39,"sex":44,"minAge":45,"maxAge":10,"enrollmentInfo":46,"targetDuration":10,"studyType":49,"phases":10,"briefSummary":50,"conditions":51,"keywords":53,"overallStatus":55,"whyStopped":10,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},{"fullName":5,"class":6},"Sohag University","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":10},"Patients with intermediate-stage hepatocellular carcinoma (BCLC-B)",null,[12],{"name":13,"role":14,"phone":15,"phoneExt":10,"email":16},"Mohammed Hamdy","CONTACT","+201101501551","mohammedzohry2018@gmail.com",[18],{"facility":19,"status":10,"city":20,"state":21,"zip":10,"country":22,"cosmosGeoPoint":23,"geoPoint":28,"contacts":29},"Sohag Oncology Center","Sohag","Sohag Governorate","Egypt",{"type":24,"coordinates":25},"Point",[26,27],31.69478,26.55695,{"lat":27,"lon":26},[30],{"name":13,"role":14,"phone":15,"phoneExt":10,"email":16},{"type":32,"investigatorFullName":33,"investigatorTitle":34,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Mohammed Hamdy Zohry","Resident in Internal Medicine Department, Faculty of Medicine, Sohag University",[36],{"name":19,"class":37},"OTHER_GOV","100627515",false,"NCT07449637","Real-World Treatment Patterns and Survival Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma.","Real-World Treatment Patterns and Survival Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma: An Observational Cohort Study.","Inclusion Criteria:\n\n* Aged ≥18 years.\n* Both sexes.\n* Diagnosis of hepatocellular carcinoma based on accepted radiologic or histologic criteria.\n* Classified as intermediate stage (BCLC-B) at time of decision for first-line treatment.\n* Child-Pugh A or B.\n* ECOG performance status 0-1.\n\nExclusion Criteria:\n\n* BCLC A, C, or D at diagnosis.\n* Prior curative therapy (resection, transplantation, curative ablation).\n* Missing essential data (imaging, liver function, treatment records).\n* Mixed HCC-cholangiocarcinoma.","ALL","18 Years",{"count":47,"type":48},200,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to learn about the different treatment options for intermediate-stage hepatocellular carcinoma. The main question it aims to answer is:\n\n\\- What are the survival outcomes among participants aged 18 or older who receive treatment for intermediate-stage hepatocellular carcinoma?",[52],"BCLC Stage B Hepatocellular Carcinoma",[54],"Intermediate-Stage Hepatocellular Carcinoma","NOT_YET_RECRUITING","2026-02-27",{"date":58,"type":59},"2026-03-04","ACTUAL",{"date":61,"type":48},"2026-03",{"date":63,"type":48},"2026-07",{"name":5,"class":6},1]